About Zeravion
Building a new intelligence layer for human health
Zeravion is a Swedish healthtech company based in Gothenburg, developing AI-powered longitudinal urine intelligence.
Our story
Change is the signal
Healthcare and research often interpret biological measurements as isolated results. Zeravion was founded around the idea that repeated measurements can reveal something more valuable: how an individual is changing over time.
We are combining urine biomarker science, longitudinal data and AI to build a new form of health intelligence.
Turn repeated biological measurements into meaningful intelligence.
Make longitudinal biological data useful across research, prevention and care.
Scientific approach
We work from established biomarker science and build carefully: structured data first, then models, then evidence. Claims follow validation, not the other way around.
Responsible innovation
Privacy, data quality, human oversight and transparent intended use guide how we develop. Current applications are for research use and are subject to validation and regulatory requirements.
People
Team
Dr. Peidi Liu
CEO — PhD data science, 13+ years in sequencing, proteomics and clinical data.
Sneha Sridhar
CSO — Molecular biology plus commercial expertise in diagnostics and devices.
Tabassum Jahan
Project Manager — Drives cross-functional execution and keeps partners aligned.
Commercial, regulatory and communications partner — Medtech Maze
Maria Kessling
Investment & partnerships — 25+ years bridging startups and investors, ex-Almi Invest.
Sandra Kastås
Communications & public affairs — 15+ years in strategic communication.
Paulina Jonasson
Regulatory & quality affairs — former nurse, 10+ years medtech regulatory expert.